These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs. Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846 [TBL] [Abstract][Full Text] [Related]
44. Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases. Ko JS; Marusic Z; Azzato EM; Farkas DH; Van Arnam J; Seiwerth S; Fritchie K; Patel RM; Rubin BP; Billings SD J Cutan Pathol; 2020 Jun; 47(6):509-516. PubMed ID: 32026485 [TBL] [Abstract][Full Text] [Related]
45. Genetically Engineered Mouse Model in Ewing Sarcoma. Tanaka M; Nakamura T Methods Mol Biol; 2021; 2226():183-189. PubMed ID: 33326102 [TBL] [Abstract][Full Text] [Related]
46. [Ewing/PNET sarcoma family of tumors: towards a new paradigm?]. Renard C; Ranchère-Vince D Ann Pathol; 2015 Jan; 35(1):86-97. PubMed ID: 25534668 [TBL] [Abstract][Full Text] [Related]
47. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma. Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378 [TBL] [Abstract][Full Text] [Related]
48. Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report. Arnold MA; Ballester LY; Pack SD; Abdullaev Z; Merchant M; Tsokos MG Pediatr Dev Pathol; 2014; 17(4):302-7. PubMed ID: 24735198 [TBL] [Abstract][Full Text] [Related]
53. Liquid Biopsies in Ewing Sarcoma. Krumbholz M; Metzler M Methods Mol Biol; 2021; 2226():39-45. PubMed ID: 33326092 [TBL] [Abstract][Full Text] [Related]
54. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing. Andersson C; Fagman H; Hansson M; Enlund F Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750 [TBL] [Abstract][Full Text] [Related]
55. Prostatic carcinoma with neuroendocrine differentiation harboring the EWSR1-FEV fusion transcript in a man with the WRN G327X germline mutation: A new variant of prostatic carcinoma or a member of the Ewing sarcoma family of tumors? Febres-Aldana CA; Krishnamurthy K; Delgado R; Kochiyil J; Poppiti R; Medina AM Pathol Res Pract; 2020 Feb; 216(2):152758. PubMed ID: 31831298 [TBL] [Abstract][Full Text] [Related]
58. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival. Gallegos ZR; Taus P; Gibbs ZA; McGlynn K; Gomez NC; Davis I; Whitehurst AW Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036566 [TBL] [Abstract][Full Text] [Related]
59. A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family. Riley RD; Burchill SA; Abrams KR; Heney D; Sutton AJ; Jones DR; Lambert PC; Young B; Wailoo AJ; Lewis IJ Eur J Cancer; 2003 Jan; 39(1):19-30. PubMed ID: 12504654 [TBL] [Abstract][Full Text] [Related]
60. Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics. Engvall M; Cahill N; Jonsson BI; Höglund M; Hallböök H; Cavelier L BMC Med Genomics; 2020 Jul; 13(1):106. PubMed ID: 32727569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]